). These publications have permitted us to "feel the elephant" that is aortic dissection. We consider the publications listed in Table 1 to be among the 10 most important contributions by IRAD.
). These publications have permitted us to "feel the elephant" that is aortic dissection. We consider the publications listed in Table 1 to be among the 10 most important contributions by IRAD.
In terms of the current paper on "trends" (1) over the lifetime of IRAD, we would like to make several observations.
The investigators pointed out that presenting signs and symptoms of aortic dissection did not change, but we would not have expected them to because that would require natural alterations in the biology of the disease-a process that could be expected to take millennia rather than over 2 decades.
The investigators seemed pleased that more betablockers, diuretics, and ARBs-and fewer vasodila- Board for Jarvik Heart; neither of which is relevant to this publication. Dr.
Ziganshin has reported that he has no relationships relevant to the contents of this paper to disclose.
have become impervious, coagulation is managed better intra-and post-operatively, brain protection has improved, and the importance of an "open" distal anastomosis has been recognized and disseminated.
We are disappointed that overall in-hospital mortality of type B aortic dissection did not improve and actually increased in the last 2 periods and also failed to show a positive overall impact of endovascular therapies.
We are not surprised that the chest x-ray has assumed lesser importance because undoubtedly many dissections can now be diagnosed by CT that would not even be discernible if a chest x-ray were done.
The investigators indicate that one of their goals is "to improve the care of these patients worldwide,"
and their hope is that information from their registry "be utilized to influence algorithms for diagnosis and treatment." Undoubtedly, many of the IRAD investigations and publications have served this goal.
However, we are hard-pressed to identify specific beneficial changes in practice that could be implemented on the basis of this particular paper on trends in aortic disease over the course of IRAD.
As wonderful as IRAD has been, the IRAD database method has limitations, which the investigators discuss frankly in this paper.
IRAD data are collected retrospectively, there is no core laboratory for image review, and the tertiary referral nature of the IRAD centers impairs its ability to be "representative of all patients with acute aortic dissection."
IRAD information comes from a referral hospital basis rather than a community population basis, with consequent inherent potential for misleading statistics (5). One example is the "dissection paradox," about which we have recently written (6) . IRAD identified that many dissections occur at aortic diameters below accepted criteria for intervention (6) .
However, in mathematical terms, IRAD could see only the "numerator" of the dissection fraction and does not know the denominator at risk at each different size range ( Figure 1A) . Wisely, the IRAD group did not recommend any change in intervention criteria. We recently applied mathematical analysis to the IRAD data, with input of additional information on the percentage of the normal population with aortas in all size ranges (6) . In other words, we approached the "denominator" at risk in the dissection fraction, as well as the dissected "numerator." We confirmed that, although dissections do occur at small sizes, patients with large aortas are at a 6,000-fold higher risk of experiencing aortic dissection ( Figure 1B) . (A) We confirmed that aortic size follows a modified bell curve distribution. The population at risk increases dramatically moving leftward from the right "tail" of the bell curve. The corollary of this observation is that, at small aortic sizes, a huge population is at risk; therefore, although dissections do occur, the relative risk is very low compared with the huge "at-risk" population. Modified with permission from Elefteriades and Farkas (17) . elefteriades@yale.edu.
